🇺🇸 FDA
Patent

US 10808010

Peptide inhibitors of phosphoglycerate mutase and methods of use

granted A61KA61K38/00A61K38/12

Quick answer

US patent 10808010 (Peptide inhibitors of phosphoglycerate mutase and methods of use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 15 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Oct 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 15 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K38/00, A61K38/12, A61K45/06, A61P